A new treatment option for people with anaphylaxis will soon be available. The FDA approved neffy, an epinephrine nasal spray, last week.
Test results show that the epinephrine nasal spray is just as effective as an epinephrine auto-injector in treating anaphylaxis.

Read press release here >>

The device has not yet been approved in South Africa.  We will update as soon as further information is available.   In the interim, patients can visit www.neffy.com to register for product updates.